Belfast Telegraph
The stigma is falling away... psychedelics will one day be available on NHS, says drugs reform campaigner Amanda Feilding
Healing Trauma at Its Roots
Entheogenic medicines work at the deepest level of the brain, releasing emotional trauma that has been locked in place for years or decades. They dissolve the conditioned responses that keep people trapped in cycles of fear, hypervigilance, and pain.
These medicines also expand awareness and openness, helping people understand perspectives beyond their own, and connect more deeply with others.
Entheogenic plant medicines were used across these lands for thousands of years before falling out of practice in recent centuries. Today, modern research is confirming what ancient cultures knew: these substances can catalyse profound healing. When even one or two people in a community begin to heal, the effects ripple outward through families and relationships.
Former conflict zones carry generations of trauma. The violence may have quietened, yet its imprint remains in our bodies, our families, and our communities.
It is time to bring these medicines safely and legally to places like Northern Ireland, guided by trained professionals, so that our communities can access the lasting healing they deserve.
Discussions in Local Media
Irish Times
Agony and Ecstasy: Psychedelics as the next big health remedy?
Irish News
Psychedelic drug effects like near-death experience
Discussions Around the World
The Independent
Psychedelic drugs can help the brain repair itself from depression and anxiety
Quillette
The Case for Psychedelics
Vox
I took magic mushrooms at a research hospital. This is what I learned.
The New Yorker
The Trip Treatment
New York Times
Taking Ayahuasca When You're a Senior Citizen
Forbes
5-MeO-DMT: The 20-Minute Psychoactive Toad Experience That's Transforming Lives
The Guardian
We should be using psychedelic drugs to treat depression
BBC
Magic mushrooms 'reboot' brain in depressed people
TED
Rick Doblin: The future of psychedelic-assisted psychotherapy
Psychedelics for Peace
Imperial College London
Could psychedelic ceremonies help people navigate a path to peace?
Zendo Project
Zendo Project - Psychedelic Peer Support
MAPS
Can Psychedelics Play a Role in Making Peace and Healing Cycles of Trauma?
Scientific Research
Nature Medicine
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
PsyPost
New research provides evidence that a single dose of psilocybin can boost brain connections
Psychedelic Science Review
The Top 10 Psychedelic Research Papers of the Last 10 Years
PsyPost
Previous antidepressant use may blunt the effectiveness of MDMA-assisted psychotherapy for PTSD
Imperial College London
LSD alters consciousness by breaking down barriers in the brain
PubMed: Cancer Study
Combining therapy with the psychedelic drug psilocybin results in large reductions in anxiety and depression
Scientific American
MDMA Could Be Tailored to Make It More Suitable for Treating Mental Illness
NCBI
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Nature
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo
Nature
An Amazonian tea stimulates the formation of new neurons
PsyPost
People who microdose psychedelic drugs report that the benefits greatly outweigh the drawbacks
PsyPost
A single dose of 5-MeO-DMT produces rapid and persistent improvements in life satisfaction and psychopathological symptoms
Inverse
Neuroscientists uncover how magic mushrooms "rebalance" the brain
Springer
Therapeutic potential of ayahuasca in grief: a prospective, observational study
PsyPost
Scientists find magic mushrooms could help fight fascism
Yale News
New research confirms lingering mood benefit of psychedelics
Yale News
Psychedelic spurs growth of neural connections lost in depression
Vox
How meditation and psychedelic drugs could fix tribalism
CNN
A woman took 550 times the usual dose of LSD, with surprisingly positive consequences
NEJM
First-of-its-kind study pits psilocybin against a common antidepressant
Nature
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
PubMed: Depression Study
Psilocybin Causes 'Significant Reduction' in Symptoms of Depression, Largest of its Kind Study Shows
NEJM
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
bioRxiv
Acute psilocybin enhances cognitive flexibility in rats
Health Aspects
Frontiers in Psychiatry
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use
New Atlas
LSD microdose trial for acute pain relief reports "remarkable" results
Springer/Psychopharmacology
Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits
EA Forum
Treating Cluster Headaches Using N,N-DMT and Other Tryptamines
Mad Science
Psychedelics and (treating) schizophrenia
PsyPost
Emotional breakthroughs during psychedelic experiences linked to future increases in mental well-being
PLOS ONE
Psychedelics and mental health: a population study
Vox
The case for funding psychedelics to treat mental health
Medical Xpress
Phase 1 clinical trials for psilocybin show no adverse effects
PsyPost
Psilocybin produces an immunology-related genetic response in the prefrontal cortex of pig brains
Trauma Research Foundation
Study shows psilocybin-assisted therapy four times more effective for major depression
PsyPost
Psilocybin study finds that it works wonders, quickly and effectively treating depression
PsyPost
Study suggests psilocybin can positively change emotions and brain function long-term
Psychedelic Science Review
Can Psilocybin and LSD Relieve Existential Suffering?
HighExistence
Psilocybin and the Shadow: Psychedelic Mushrooms as a Tool For Healing Emotional Trauma
Third Wave
Microdosing LSD for Alzheimer's proves safe in early human trial
PsyPost
MDMA-assisted couples therapy: How a psychedelic is enhancing intimacy and healing PTSD
Clusterbusters
Legalising access to psilocybin to end the agony of cluster headaches
MAPS: MDMA
Silicon Valley's psychedelic wonder drug is almost here
Vice
Can a Trip-Free Psychedelic Still Help People With Depression?
Inverse
Magic Mushroom study suggests Psilocybin may reverse alcohol-induced brain damage
ICEERS
Lacking a medical solution, ayahuasca saved my life
Outside Magazine
Jim Harris Was Paralyzed. Then He Ate Magic Mushrooms
Beckley Foundation
Ayahuasca Stimulates the Birth of New Brain Cells
Decriminalization, Awareness, and Understanding
New Atlas
Psilocybin for major depression granted Breakthrough Therapy by FDA
Johns Hopkins Hub
Johns Hopkins launches center for psychedelic research
DoubleBlind Mag
Santa Cruz City Council Votes to Decriminalize Entheogenic Plants and Fungi
Psychedelic Science Review
Chicago Follows Oakland, Introduces Resolution to Decriminalize Psychedelic Plants
Marijuana Moment
Nearly 100 Cities Are Considering Decriminalizing Psychedelics, Map Shows
DoubleBlind Mag
Canada Now Has Psilocybin Dispensaries
Forbes
Four Terminally Ill Canadians Gain Legal Right To Use Magic Mushrooms For End-Of-Life Distress
Nature
How ecstasy and psilocybin are shaking up psychiatry
Wired
Big pharma is about to tune in to the potential of psychedelics
Newsweek
Magic mushrooms one step closer to treating depression after successful clinical trials
Slate
D.C. and Oregon Vote to Start Decriminalizing Shrooms
DoubleBlind Magazine
Will Shroom Dispensaries Become a Thing Anytime Soon?
New Atlas
MDMA for PTSD granted Expanded Access by FDA, patient treatments begin
CBC News
First patient in Quebec gets approval from Health Canada for magic mushroom therapy
Forbes
Australia Becomes First Country to Legalize Therapeutic Use of MDMA and Psilocybin
DoubleBlind Mag
Prescription Psychedelics are Almost Here—But Western Medicine Isn't Ready
The Guardian
Australian psychiatrists can now prescribe MDMA and psilocybin. Who can access them and how do they work?
Marijuana Moment
Psilocybin Research Bill Unanimously Approved in Arizona with Bipartisan Support
Links to Organisations and Further Resources
ICEERS
Transforming Society's Relationships with Psychoactive Plants
MAPS
MAPS is a leader in psychedelic research. Since 1986, MAPS has been on a mission to create safe, legal, and beneficial opportunities for psychedelics in medicine and society.
The Beckley Foundation
The Beckley Foundation pioneers psychedelic research to drive evidence-based drug policy reform, founded and directed by Amanda Feilding as a UK-based think-tank and NGO.
Enthea
Enthea is a research project assessing the hypothesis that the world would be better if more people had experiences with psychedelics
Entheonation
We provide deeply researched content about psychedelics – primarily natural psychedelics long-used by indigenous people around the world – and how you can work with them for healing and spiritual growth.
Psychedelic Science Review
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible.
The Psychedelic Society
We create life-affirming experiences to connect people with themselves, each other, the natural world and the mystery of existence.
Transform Drug Policy Foundation
We are dedicated to making safer drug policies a reality. This means ending prohibition and replacing it with a system of legal regulation for all drugs.
International Drug Policy Consortium
A global network of organisations and professionals advocating for drug policies grounded in social justice, human rights, and public health.
Usona Institute
Usona Institute is a 501(c)(3) non-profit medical research organization dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin.
Heffter Research Institute
Advancing studies on psilocybin for treatment of addictions and other mental disorders, with the highest standards of scientific research
Psychedelic Experience (PEx)
We aim to reduce harm and stigma associated with psychedelics by helping to best inform users, offer tools to help with integration of their experiences, and a space for communal support.
Johns Hopkins Center for Psychedelic & Consciousness Research
After a decades-long hiatus, in 2000 our research group at Johns Hopkins was the first to obtain regulatory approval in the United States to reinitiate research with psychedelics in healthy, psychedelic-naive volunteers.
The History of Psychedelics (Part 1 of 2)
Visual Capitalist infographic on the history of psychedelics
The History of Psychedelics (Part 2 of 2)
Visual Capitalist infographic on the history of psychedelics